EA200000881A1 - Способ получения симвастатина и его производных - Google Patents

Способ получения симвастатина и его производных

Info

Publication number
EA200000881A1
EA200000881A1 EA200000881A EA200000881A EA200000881A1 EA 200000881 A1 EA200000881 A1 EA 200000881A1 EA 200000881 A EA200000881 A EA 200000881A EA 200000881 A EA200000881 A EA 200000881A EA 200000881 A1 EA200000881 A1 EA 200000881A1
Authority
EA
Eurasian Patent Office
Prior art keywords
derivatives
improve
simvastatin
precursor
obtaining
Prior art date
Application number
EA200000881A
Other languages
English (en)
Other versions
EA002370B1 (ru
Inventor
Сильво Зупанчич
Антон Штимак
Еже Гнидовек
Original Assignee
Крка Товарна, Здравил, Д.Д.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Крка Товарна, Здравил, Д.Д. filed Critical Крка Товарна, Здравил, Д.Д.
Publication of EA200000881A1 publication Critical patent/EA200000881A1/ru
Publication of EA002370B1 publication Critical patent/EA002370B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Описан способ получения симвастатина и его производных, в котором для улучшения защиты лактона-предшественника и улучшения протекания реакции ацилирования, используемой для введения необходимой боковой цепи в положение 8 гексагидронафталинового цикла, используется N-метилимидазол.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200000881A 1998-02-26 1999-02-24 Способ получения симвастатина и его производных EA002370B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI9800057A SI9800057A (sl) 1998-02-26 1998-02-26 Postopek za pripravo simvastatina in njegovih derivatov
PCT/SI1999/000006 WO1999043665A1 (en) 1998-02-26 1999-02-24 Process for the preparation of simvastatin and derivatives thereof

Publications (2)

Publication Number Publication Date
EA200000881A1 true EA200000881A1 (ru) 2001-02-26
EA002370B1 EA002370B1 (ru) 2002-04-25

Family

ID=20432210

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000881A EA002370B1 (ru) 1998-02-26 1999-02-24 Способ получения симвастатина и его производных

Country Status (18)

Country Link
US (1) US6252091B1 (ru)
EP (1) EP1056737B1 (ru)
AT (1) ATE243207T1 (ru)
AU (1) AU3284699A (ru)
BG (1) BG64826B1 (ru)
CZ (1) CZ297405B6 (ru)
DE (1) DE69908909T2 (ru)
EA (1) EA002370B1 (ru)
EE (1) EE04345B1 (ru)
HR (1) HRP20000467B1 (ru)
HU (1) HU227916B1 (ru)
NO (1) NO326301B1 (ru)
PL (1) PL194713B1 (ru)
RS (1) RS49712B (ru)
SI (1) SI9800057A (ru)
SK (1) SK284137B6 (ru)
UA (1) UA56303C2 (ru)
WO (1) WO1999043665A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI20116A (sl) * 1998-12-02 2000-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nov postopek za pripravo simvastatina in njegovih analogov
EP1055671B1 (en) * 1998-12-10 2004-12-01 Kaneka Corporation A process for producing a simvastatin precursor
AU2127500A (en) 1999-11-11 2001-06-06 Biocon India Limited Process for manufacturing simvastatin and the novel intermediates
US6573385B1 (en) 1999-11-11 2003-06-03 Biocon India Limited Process for manufacturing simvastatin and novel intermediates thereof
IL154068A0 (en) 2000-07-27 2003-07-31 Teva Pharma Highly purified simvastatin compositions
US6603022B1 (en) 2002-05-10 2003-08-05 Biocon India Limited Process for manufacturing Simvastatin and novel intermediates thereof
SK285772B6 (sk) * 2002-11-20 2007-08-02 Zentiva, A. S. Spôsob prípravy simvastatínu
CN102070587B (zh) * 2011-01-13 2015-10-14 广东东阳光药业有限公司 一锅法制备辛伐他汀的方法
WO2014168933A1 (en) 2013-04-08 2014-10-16 Cytodyn Inc. Felinized antibodies and methods of treating retroviral infections in felines
CN104356120B (zh) * 2014-10-17 2017-05-03 上海应用技术学院 多取代喹啉类他汀内酯脱水化合物及其用途
CN104311517B (zh) * 2014-10-17 2017-06-06 上海应用技术学院 他汀内酯脱水化合物及其用途
CN105111173B (zh) * 2015-06-26 2017-06-23 上海应用技术学院 他汀含氟衍生物及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU535944B2 (en) 1979-06-15 1984-04-12 Merck & Co., Inc. Hypocholestermic fermentation products from aspergillus
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
EP0137445B1 (en) * 1983-10-11 1990-01-03 Merck & Co. Inc. Process for c-methylation of 2-methylbutyrates
US4845237A (en) * 1987-04-15 1989-07-04 Merck & Co., Inc. Acylation process for the synthesis of HMG-CoA reductase inhibitors
US4820850A (en) * 1987-07-10 1989-04-11 Merck & Co., Inc. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
CA2036962C (en) 1990-02-26 1998-09-15 Ann E. Decamp Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one
US5223415A (en) * 1990-10-15 1993-06-29 Merck & Co., Inc. Biosynthetic production of 7-[1',2',6',7',8',8a'(R)-hexahydro-2'(S),6'(R)-dimethyl-8'(S)-hydroxy-1'(S)-naphthyl]-3(R),5(R)-dihydroxyheptanoic acid (triol acid)
SI9500238A (en) 1995-07-27 1997-02-28 Krka Tovarna Zdravil Procedure for the production of lovastatin

Also Published As

Publication number Publication date
EP1056737B1 (en) 2003-06-18
EA002370B1 (ru) 2002-04-25
UA56303C2 (ru) 2003-05-15
BG104749A (en) 2001-04-30
CZ20002857A3 (cs) 2000-11-15
EP1056737A1 (en) 2000-12-06
HUP0100743A2 (hu) 2001-11-28
HRP20000467A2 (en) 2001-02-28
HUP0100743A3 (en) 2002-04-29
SI9800057A (sl) 1999-08-31
CZ297405B6 (cs) 2006-12-13
HRP20000467B1 (en) 2009-02-28
BG64826B1 (bg) 2006-05-31
US6252091B1 (en) 2001-06-26
EE04345B1 (et) 2004-08-16
NO20004221D0 (no) 2000-08-23
AU3284699A (en) 1999-09-15
HU227916B1 (en) 2012-06-28
DE69908909T2 (de) 2003-12-04
SK284137B6 (sk) 2004-09-08
NO20004221L (no) 2000-08-23
WO1999043665A1 (en) 1999-09-02
SK12582000A3 (sk) 2002-01-07
PL342511A1 (en) 2001-06-18
ATE243207T1 (de) 2003-07-15
EE200000479A (et) 2002-02-15
NO326301B1 (no) 2008-11-03
YU46600A (sh) 2003-12-31
DE69908909D1 (de) 2003-07-24
RS49712B (sr) 2007-12-31
PL194713B1 (pl) 2007-06-29

Similar Documents

Publication Publication Date Title
EA200000881A1 (ru) Способ получения симвастатина и его производных
CY1105836T1 (el) 12, 13-τροποποιημενα παραγωγα εποθιλονης
EA200000539A1 (ru) Способ получения производных класса таксоидов
EA200300187A1 (ru) Способ получения n-арилантраниловых кислот и их производных
EA200001187A1 (ru) Полиморфная форма гидросульфата клопидогрела
EA200101081A1 (ru) Способ получения циталопрама
DE69709938T2 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
EA200400252A1 (ru) Стабильная полиморфная модификация флибансерина, способ её промышленного получения и её применение для получения лекарственных средств
PT1125907E (pt) Intermediarios para a producao de citalopram
EA200000094A1 (ru) Способ получения замещенного пергидроизоиндола
EA200200999A1 (ru) Комбинированный профиль и способ получения комбинированного профиля
EA199800792A1 (ru) Способы получения промежуточных соединений для пестицидов
ES2151977T3 (es) Inhibidores de accion doble que contienen 1,2-diazepina.
EA199900027A1 (ru) Способ получения некоторых азациклогексапептидов
EA200100297A1 (ru) Моногидрат гидробромида элетриптана
DE60001487T2 (de) Polynalbuphinderivat
EA199900741A1 (ru) Способ получения эпросартана
EA200200971A1 (ru) Способ получения циталопрама
EA200000069A1 (ru) Способ получения 4-замещенных-1h-индол-3-глиоксамидов
ID26587A (id) Proses sintesa inhibitor proteasa hiv
EA200301224A1 (ru) Способ получения имипенема
EA200101001A1 (ru) Декурсинол или его производное в качестве аналгезирующего средства
EA199900735A1 (ru) Соединения и способ получения замещенных 4-фенил-4-цианоциклогексановых кислот
EA199800027A1 (ru) СПОСОБ СИНТЕЗА БЕНЗО[b]ТИОФЕНОВ
EA199800040A1 (ru) СПОСОБ СИНТЕЗА БЕНЗО/b/ТИОФЕНОВ

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY MD

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU